Fundies. English
Segment disclosures
Company overviewTransMedics Group, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
23 dimension combinations 266 retained observations 17 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Liver Product · Ocs Transplant Revenue · US
Product Or Service · Statement Business Segments · Statement Geographical
Source dimensions
srt:ProductOrServiceAxis=tmdx:LiverProductMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 66926000 | USD | 20240502 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 151719000 | USD | 20240227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 41214000 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 97002000 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 23114000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 46169000 | USD | 20240227 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 30030000 | USD | 20231108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1915000 | USD | 20240227 | Open filing evidence |
Liver Product · Ocs Transplant Revenue · Other Countries
Product Or Service · Statement Business Segments · Statement Geographical
Source dimensions
srt:ProductOrServiceAxis=tmdx:LiverProductMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:StatementGeographicalAxis=tmdx:OtherCountriesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 104000 | USD | 20240227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 97000 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 104000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 90000 | USD | 20240227 | Open filing evidence |
Lung Product · Other Countries · Ocs Transplant Revenue
Product Or Service · Statement Geographical · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=tmdx:LungProductMember;srt:StatementGeographicalAxis=tmdx:OtherCountriesMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 1418000 | USD | 20260224 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1181000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 375000 | USD | 20250508 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 182000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 448000 | USD | 20250730 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1272000 | USD | 20260224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 310000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 964000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 403000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 654000 | USD | 20240801 | Open filing evidence |
Lung Product · Non Us · Ocs Transplant Revenue
Product Or Service · Statement Geographical · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=tmdx:LungProductMember;srt:StatementGeographicalAxis=us-gaap:NonUsMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 409000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1036000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 627000 | USD | 20260505 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 421000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 796000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 375000 | USD | 20260505 | Open filing evidence |
Lung Product · Ocs Transplant Revenue · US
Product Or Service · Statement Business Segments · Statement Geographical
Source dimensions
srt:ProductOrServiceAxis=tmdx:LungProductMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2253000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 4450000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 2197000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 13443000 | USD | 20260224 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3725000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11515000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 4154000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 7790000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 3636000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 15755000 | USD | 20260224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3726000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 12675000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 4243000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 8949000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4706000 | USD | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 10548000 | USD | 20260224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3410000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 7658000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2817000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4248000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1431000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 7967000 | USD | 20250227 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1438000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 6033000 | USD | 20231108 | Open filing evidence |
Lung Product · Ocs Transplant Revenue · Other Countries
Product Or Service · Statement Business Segments · Statement Geographical
Source dimensions
srt:ProductOrServiceAxis=tmdx:LungProductMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:StatementGeographicalAxis=tmdx:OtherCountriesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 960000 | USD | 20240502 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1272000 | USD | 20240227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 310000 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 964000 | USD | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 161000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 703000 | USD | 20231108 | Open filing evidence |
Other Countries · Lung Product · Ocs Transplant Revenue
Statement Geographical · Product Or Service · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=tmdx:OtherCountriesMember;srt:ProductOrServiceAxis=tmdx:LungProductMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 385000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 421000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 796000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1926000 | USD | 20260224 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1590000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1408000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 960000 | USD | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1272000 | USD | 20250227 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 880000 | USD | 20250227 | Open filing evidence |
Other Countries · Ocs Transplant Revenue
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=tmdx:OtherCountriesMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 16700000 | USD | 20260224 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3630000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11855000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 4160000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8225000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 4065000 | USD | 20250508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 15282000 | USD | 20260224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2583000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 11390000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 4716000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 8807000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4091000 | USD | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 15388000 | USD | 20260224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 4300000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11871000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3518000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 7571000 | USD | 20240801 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 9421000 | USD | 20250227 | Open filing evidence |
Other Countries · Ocs Transplant Revenue · Heart Product
Statement Geographical · Statement Business Segments · Product Or Service
Source dimensions
srt:StatementGeographicalAxis=tmdx:OtherCountriesMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:ProductOrServiceAxis=tmdx:HeartProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 14169000 | USD | 20260224 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3187000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 10232000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3495000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 7045000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 3550000 | USD | 20250508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 13198000 | USD | 20260224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2401000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 9800000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 4268000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 7399000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 3131000 | USD | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 14012000 | USD | 20260224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3893000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 10803000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3108000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 6910000 | USD | 20240801 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 8451000 | USD | 20250227 | Open filing evidence |
Other Countries · Ocs Transplant Revenue · Liver Product
Statement Geographical · Statement Business Segments · Product Or Service
Source dimensions
srt:StatementGeographicalAxis=tmdx:OtherCountriesMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:ProductOrServiceAxis=tmdx:LiverProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 1113000 | USD | 20260224 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 58000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 442000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 244000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 384000 | USD | 20250730 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 140000 | USD | 20250508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 158000 | USD | 20260224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250730 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 104000 | USD | 20260224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 97000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 104000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 7000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 7000 | USD | 20240801 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 90000 | USD | 20250227 | Open filing evidence |
Non Us · Ocs Transplant Revenue
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=us-gaap:NonUsMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 5241000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 10889000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 5648000 | USD | 20260505 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 4160000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8225000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 4065000 | USD | 20260505 | Open filing evidence |
Non Us · Ocs Transplant Revenue · Heart Product
Statement Geographical · Statement Business Segments · Product Or Service
Source dimensions
srt:StatementGeographicalAxis=us-gaap:NonUsMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:ProductOrServiceAxis=tmdx:HeartProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 4587000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 9598000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 5011000 | USD | 20260505 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3495000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 7045000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 3550000 | USD | 20260505 | Open filing evidence |
Non Us · Ocs Transplant Revenue · Liver Product
Statement Geographical · Statement Business Segments · Product Or Service
Source dimensions
srt:StatementGeographicalAxis=us-gaap:NonUsMember;us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:ProductOrServiceAxis=tmdx:LiverProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 245000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 255000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 10000 | USD | 20260505 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 244000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 384000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 140000 | USD | 20260505 | Open filing evidence |
Ocs Transplant Revenue
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 188864000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 361536000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 172672000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 601397000 | USD | 20260224 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 142639000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 441668000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 156347000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 299029000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 142682000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 437162000 | USD | 20260224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 107505000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 316623000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 113171000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 209118000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 95947000 | USD | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 236735000 | USD | 20260224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 63993000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 158012000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 52465000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 94019000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 41554000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 93459000 | USD | 20250227 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 25683000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 62084000 | USD | 20231108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 30262000 | USD | 20240227 | Open filing evidence |
Ocs Transplant Revenue · Heart Product · US
Statement Business Segments · Product Or Service · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:ProductOrServiceAxis=tmdx:HeartProductMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 25857000 | USD | 20260505 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 27401000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 26266000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 96663000 | USD | 20250227 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 24525000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 71922000 | USD | 20241029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 27173000 | USD | 20240801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 47397000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 20224000 | USD | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 59080000 | USD | 20250227 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 12956000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 29902000 | USD | 20240227 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 10103000 | USD | 20240227 | Open filing evidence |
Ocs Transplant Revenue · Heart Product · Other Countries
Statement Business Segments · Product Or Service · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:ProductOrServiceAxis=tmdx:HeartProductMember;srt:StatementGeographicalAxis=tmdx:OtherCountriesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 3131000 | USD | 20240502 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 14012000 | USD | 20240227 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 3802000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 8451000 | USD | 20240227 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 7579000 | USD | 20240227 | Open filing evidence |
Ocs Transplant Revenue · Liver Product · US
Statement Business Segments · Product Or Service · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:ProductOrServiceAxis=tmdx:LiverProductMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 147989000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 286959000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 138970000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 459415000 | USD | 20260224 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 107883000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 332460000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 115862000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 224577000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 108715000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 309462000 | USD | 20260224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 76671000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 220636000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 77039000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 143965000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 66926000 | USD | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 151719000 | USD | 20260224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 41214000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 97002000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 32674000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 55788000 | USD | 20240801 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 46169000 | USD | 20250227 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 12543000 | USD | 20231108 | Open filing evidence |
Ocs Transplant Revenue · Lung Product · US
Statement Business Segments · Product Or Service · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:ProductOrServiceAxis=tmdx:LungProductMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 4706000 | USD | 20240502 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 9843000 | USD | 20240227 | Open filing evidence |
Ocs Transplant Revenue · Lung Product · Other Countries
Statement Business Segments · Product Or Service · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:ProductOrServiceAxis=tmdx:LungProductMember;srt:StatementGeographicalAxis=tmdx:OtherCountriesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 251000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 880000 | USD | 20240227 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 822000 | USD | 20240227 | Open filing evidence |
Ocs Transplant Revenue · US
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:StatementGeographicalAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 183623000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 350647000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 167024000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 584697000 | USD | 20260224 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 139009000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 429813000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 152187000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 290804000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 138617000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 421880000 | USD | 20260224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 104922000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 305233000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 108455000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 200311000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 91856000 | USD | 20250508 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 221347000 | USD | 20260224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 59693000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 146141000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 48947000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 86448000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 37501000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 84038000 | USD | 20250227 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 23285000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 54984000 | USD | 20231108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 21861000 | USD | 20240227 | Open filing evidence |
Ocs Transplant Revenue · US · Heart Product
Statement Business Segments · Statement Geographical · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:StatementGeographicalAxis=country:US;srt:ProductOrServiceAxis=tmdx:HeartProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 33381000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 59238000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 111839000 | USD | 20260224 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 85838000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 32171000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 58437000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 26266000 | USD | 20250508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 96663000 | USD | 20260224 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 24525000 | USD | 20241029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 71922000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 27173000 | USD | 20250730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 47397000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 59080000 | USD | 20260224 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 15069000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 41481000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 13456000 | USD | 20240801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 26412000 | USD | 20240801 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 29902000 | USD | 20250227 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 9304000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 18921000 | USD | 20231108 | Open filing evidence |
Ocs Transplant Revenue · Other Countries
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:StatementGeographicalAxis=tmdx:OtherCountriesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 4091000 | USD | 20240502 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 15388000 | USD | 20240227 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 4300000 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11871000 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4053000 | USD | 20240502 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 9421000 | USD | 20240227 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2398000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 7100000 | USD | 20231108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 8401000 | USD | 20240227 | Open filing evidence |
Ocs Transplant Revenue · Other Countries · Heart Product
Statement Business Segments · Statement Geographical · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=tmdx:OcsTransplantRevenueMember;srt:StatementGeographicalAxis=tmdx:OtherCountriesMember;srt:ProductOrServiceAxis=tmdx:HeartProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 3893000 | USD | 20231108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 10803000 | USD | 20231108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2237000 | USD | 20231108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 6397000 | USD | 20231108 | Open filing evidence |